Clinical Trial
Study Details
Enrollment
1665
Phase
N/A
Status
COMPLETED
Study ID #
NCT06662812
Study Type
Observational
Summary
This was a retrospective observational cohort study. This study was a secondary analysis of individuals with sickle cell disease (SCD) enrolled in the GRNDaD registry.
Study Overview
Conditions
Contacts and Locations
Locations
Facility
Novartis Pharmaceuticals
East Hanover, New Jersey 07936
United States
GeoPoint
40.8201, -74.36487